Lisanti Capital Growth, LLC Karuna Therapeutics, Inc. Transaction History

Lisanti Capital Growth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$176.32 - $240.22 $878,073 - $1.2 Million	4,980 New	4,980 $1.08 Million
Q4 2022 Feb 03, 2023	SELL	$191.53 - $236.82 $2.26 Million - $2.8 Million	-11,820 Reduced 64.05%	6,635 $1.3 Million
Q3 2022 Nov 01, 2022	BUY	$123.79 - $277.42 $2.28 Million - $5.12 Million	18,455 New	18,455 $4.15 Million
Q3 2020 Nov 05, 2020	SELL	$71.31 - $109.74 $2.73 Million - $4.2 Million	-38,290 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$62.14 - $117.21 $1.45 Million - $2.73 Million	23,280 Added 155.1%	38,290 $4.27 Million
Q1 2020 May 11, 2020	BUY	$60.41 - $115.92 $906,754 - $1.74 Million	15,010 New	15,010 $1.08 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.